|
WO2021021996A1
|
|
Methods of treating disorders associated with elevated levels of antibodies that interact with the nmda receptor
|
|
BR112020015666A2
|
|
nmda receptor spiro-lactam modulators and their uses
|
|
WO2019152681A1
|
|
Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
|
|
BR112020015710A2
|
|
SPIRAL-LACTAM MODULATORS OF NMDA RECEPTORS AND USES OF THE SAME
|
|
WO2019152696A1
|
|
Spiro-lactam nmda receptor modulators and uses thereof
|
|
WO2019152688A1
|
|
Spiro-lactam nmda receptor modulators and uses thereof
|
|
WO2019152685A1
|
|
Spiro-lactam nmda receptor modulators and methods of using same
|
|
SG11201900551WA
|
|
Spiro-lactam nmda receptor modulators and uses thereof
|
|
AU2017306164A1
|
|
Spiro-lactam NMDA modulators and methods of using same
|
|
EP3490992A1
|
|
Spiro-lactam nmda receptor modulators and uses thereof
|
|
CN109661398A
|
|
Spiral shell-lactams and two-spiral shells-lactams nmda receptor regulator and application thereof
|
|
MX2019001318A
|
|
Spiro-lactam nmda receptor modulators and uses thereof.
|
|
WO2017201285A1
|
|
Spiro-lactam nmda receptor modulators and uses thereof
|
|
MX2018014202A
|
|
Spiro-lactam nmda receptor modulators and uses thereof.
|
|
AU2014212501A1
|
|
Spiro-lactam NMDA receptor modulators and uses thereof
|
|
HUE043843T2
|
|
Spiro-lactam nmda receptor modulators and uses thereof
|
|
MX2015009772A
|
|
Spiro-lactam nmda receptor modulators and uses thereof.
|
